Lilly goes for private launch of first-in-class diabetes therapy

"We are thrilled to introduce MOUNJARO, which represents the first new class of type 2 diabetes medication introduced in almost a decade and embodies our mission to bring innovative new therapies to the Australian diabetes community," said Tori Brown, the general manager of Eli Lilly Australia. …